TRPV1 and irritable bowel syndrome: TRPV1 blockade by the non-selective antagonist capsazepine, JNJ 10185734, BCTC and SB366791 in various models of colitis exerted anti-inflammatory actions supporting the pathogenic role of TRPV1 in experimental IBD [55,56,57,58,59].